Related references
Note: Only part of the references are listed.CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair
Anna J. Jasinska et al.
FRONTIERS IN IMMUNOLOGY (2022)
CCL5 Levels Predict Stroke Volume Growth in Acute Ischemic Stroke and Significantly Diminish in Hemorrhagic Stroke Patients
Francisco Jose Julian-Villaverde et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Increased Oxidative Stress Markers in Acute Ischemic Stroke Patients Treated with Thrombolytics
Hanna Pawluk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis
Xiongfeng Pan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Role of inflammatory chemokines in hypertension
Tomasz P. Mikolajczyk et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Brain-derived CCR5 Contributes to Neuroprotection and Brain Repair after Experimental Stroke
Suning Ping et al.
AGING AND DISEASE (2021)
Chemokine Receptor 5, a Double-Edged Sword in Metabolic Syndrome and Cardiovascular Disease
Zhongwen Zhang et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke
Hanna Pawluk et al.
CLINICAL INTERVENTIONS IN AGING (2020)
Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis
Hanna Pawluk et al.
CLINICAL INTERVENTIONS IN AGING (2020)
CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury
Mary T. Joy et al.
CELL (2019)
Vascular endothelial growth factor-modified macrophages accelerate reendothelialization and attenuate neointima formation after arterial injury in atherosclerosis-prone mice
Dan Yan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Vis-a-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis
Concetta Scimone et al.
NEUROLOGICAL SCIENCES (2019)
Treatment failure in neovascular age-related macular degeneration is associated with a complex chemokine receptor profile
Thomas Bjerregaard et al.
BMJ OPEN OPHTHALMOLOGY (2019)
Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017
Theodore Wein et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy
N. Suffee et al.
SCIENTIFIC REPORTS (2017)
Knockdown of C-C Chemokine Receptor 5 (CCR5) is Protective Against Cerebral Ischemia and Reperfusion Injury
Edna Constanza Gomez Victoria et al.
CURRENT NEUROVASCULAR RESEARCH (2017)
CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study
Concetta Scimone et al.
BMC MEDICAL GENETICS (2016)
Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and infl ammation
Angel Chamorro et al.
LANCET NEUROLOGY (2016)
Reparative inflammation takes charge of tissue regeneration
Michael Karin et al.
NATURE (2016)
MKEY, a Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, Protects Against Stroke in Mice
Yifang Fan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice
Zhongwen Zhang et al.
STEM CELL RESEARCH & THERAPY (2015)
Factors Influencing the Decline in Stroke Mortality A Statement From the American Heart Association/American Stroke Association
Daniel T. Lackland et al.
STROKE (2014)
RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke
Himiko Tokami et al.
BRAIN RESEARCH (2013)
The RANTES gene promoter polymorphisms are associated with the risk of atherothrombotic cerebral infarction in Northern Han Chinese
Xue Qin et al.
CLINICA CHIMICA ACTA (2011)
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study
Salim S. Virani et al.
EUROPEAN HEART JOURNAL (2011)
Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system
William Rostene et al.
JOURNAL OF NEUROCHEMISTRY (2011)
In Vivo Real-Time Multiphoton Imaging of T Lymphocytes in the Mouse Brain After Experimental Stroke
Stefano Fumagalli et al.
STROKE (2011)
Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5
S. Sorce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke
Fabrizio Montecucco et al.
STROKE (2010)
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions
Ingo Bartholomaeus et al.
NATURE (2009)
Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury
Takashi Shichita et al.
NATURE MEDICINE (2009)
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Arthur Liesz et al.
NATURE MEDICINE (2009)
Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
Mathias Gelderblom et al.
STROKE (2009)
Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion
Satoshi Terao et al.
STROKE (2008)
T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation
Patricia D. Hurn et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Inflammation and infection in clinical stroke
HCA Emsley et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Share Paper
